Enzo Biochem, Inc. (NYSE:ENZ) to Issue Quarterly Dividend of $0.10

Enzo Biochem, Inc. (NYSE:ENZGet Free Report) announced a quarterly dividend on Tuesday, October 29th, NASDAQ reports. Investors of record on Friday, November 15th will be paid a dividend of 0.10 per share by the medical research company on Monday, December 2nd. This represents a $0.40 dividend on an annualized basis and a yield of 34.48%. The ex-dividend date is Friday, November 15th.

Enzo Biochem Stock Up 2.7 %

NYSE:ENZ opened at $1.16 on Thursday. Enzo Biochem has a twelve month low of $0.99 and a twelve month high of $1.50. The business has a 50 day moving average price of $1.13 and a two-hundred day moving average price of $1.11.

Analyst Ratings Changes

Separately, StockNews.com assumed coverage on shares of Enzo Biochem in a report on Wednesday. They set a “hold” rating for the company.

Check Out Our Latest Stock Analysis on ENZ

Enzo Biochem Company Profile

(Get Free Report)

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.

Further Reading

Receive News & Ratings for Enzo Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzo Biochem and related companies with MarketBeat.com's FREE daily email newsletter.